TY - JOUR
T1 - Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis
AU - Moosa, Mahomed Yunus S.
AU - Alangaden, George J.
AU - Manavathu, Elias
AU - Chandrasekar, Pranatharthi H.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - Emergence of resistance to antifungal drugs during therapy for invasive aspergillosis has received scant attention. We recovered Aspergillus isolates from six patients with invasive aspergillosis, who were receiving amphotericin B before fungal isolation. Although isolates were susceptible to amphotericin B in vitro, none of the patients survived. The MIC of amphotericin B for isolates was similar to that for isolates from 35 patients with no prior exposure to amphotericin B. Laboratory attempts to produce amphotericin B resistance in Aspergillus were unsuccessful. These data indicate that emergence of resistance to amphotericin B is uncommon during therapy for invasive aspergillosis.
AB - Emergence of resistance to antifungal drugs during therapy for invasive aspergillosis has received scant attention. We recovered Aspergillus isolates from six patients with invasive aspergillosis, who were receiving amphotericin B before fungal isolation. Although isolates were susceptible to amphotericin B in vitro, none of the patients survived. The MIC of amphotericin B for isolates was similar to that for isolates from 35 patients with no prior exposure to amphotericin B. Laboratory attempts to produce amphotericin B resistance in Aspergillus were unsuccessful. These data indicate that emergence of resistance to amphotericin B is uncommon during therapy for invasive aspergillosis.
UR - http://www.scopus.com/inward/record.url?scp=0036156656&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036156656&partnerID=8YFLogxK
U2 - 10.1093/jac/49.1.209
DO - 10.1093/jac/49.1.209
M3 - Article
C2 - 11751792
AN - SCOPUS:0036156656
VL - 49
SP - 209
EP - 213
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
SN - 0305-7453
IS - 1
ER -